INNOVIVA, INC. Interest and Other Income
INNOVIVA, INC. (INVA) reported Interest and Other Income of -$1.24 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-01.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2013-05-01
- INNOVIVA, INC. interest and other income for the quarter ending 2013-03-31 was -$1.24M, a 2308.93% decline year-over-year.
- INNOVIVA, INC. interest and other income for the quarter ending 2012-03-31 was $56.00K.
| Period end | Interest and Other Income 3 month |
|---|---|
| 2013-03-31 | -$1.24M 10-Q · filed 2013-05-01 |
| 2012-03-31 | $56.00K 10-Q · filed 2013-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |